|
|
.
See Category: Diseases of the nervous system
ICD-10 (CM) Code and Descriptor
G35 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.96%
|
15.94%
|
10.91%
|
7.69%
|
4.88%
|
3.18%
|
2.15%
|
1.39%
|
0.90%
|
0.63%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for G35*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
97110
|
THERAPEUTIC EXERCISES |
173,336
|
298,663
|
|
97530
|
THERAPEUTIC ACTIVITIES |
173,072
|
309,196
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
73,079
|
108,967
|
|
97535
|
SELF CARE MNGMENT TRAINING |
43,582
|
79,318
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
41,351
|
41,419
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
35,352
|
53,808
|
|
97116
|
GAIT TRAINING THERAPY |
33,946
|
43,852
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
33,017
|
33,028
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
31,447
|
31,592
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
28,440
|
28,777
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
25,594
|
87,302
|
|
80053
|
COMPREHEN METABOLIC PANEL |
25,371
|
25,373
|
|
92526
|
ORAL FUNCTION THERAPY |
23,022
|
23,030
|
|
96413
|
CHEMO IV INFUSION 1 HR |
22,860
|
22,865
|
|
J2323
|
NATALIZUMAB INJECTION |
21,027
|
6,261,306
|
|
92507
|
TX SP LANG VOICE COMM INDIV |
19,450
|
19,467
|
|
97542
|
WHEELCHAIR MNGMENT TRAINING |
18,274
|
31,907
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
18,141
|
27,197
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
17,960
|
17,968
|
|
J2350
|
INJECTION, OCRELIZUMAB, 1 MG |
15,248
|
8,264,239
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
G35 related to the following DRG Codes:
058-060
|
